Regulatory Affairs & Global Approval

This session focuses on the regulatory frameworks and approval pathways governing biologics and biosimilars across different global jurisdictions. Experts will compare guidelines and review processes from major agencies including the FDA, EMA, MHRA, PMDA, and WHO. Topics will include regulatory science in biosimilarity assessment, bridging studies, dossier preparation, and comparability exercises. The importance of transparency, stakeholder communication, and evidence-based submissions will be emphasized. Attendees will gain insights into accelerated pathways such as priority review and adaptive licensing, and how evolving regulations affect product development timelines and global market entry. The session also addresses challenges with global harmonization, pharmacopoeial alignment, and post-approval variation management. Regulatory professionals, compliance officers, and development strategists will benefit from practical case studies and agency updates aimed at enhancing regulatory readiness and reducing approval barriers for innovative biologics and biosimilars.

    Related Conference of Regulatory Affairs & Global Approval

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Regulatory Affairs & Global Approval Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in